Dustin Fraidenburg is a Respiratory physician affiliated with University of Illinois Chicago. OpenAlex indexes 84 publications with 827 citations (h-index 13).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1740 W Taylor St
Chicago, IL 606127232
Telephone
866-600-2273Registry record last updated 4 May 2018.
Industry payments
5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Lungpacer Medical USA IncProgram year20251 payment
- United Therapeutics CorporationProgram year20252 payments
- United Therapeutics CorporationProgram year20245 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
48.1%Endothelin Receptor Antagonist39.2%Opsumit54%Ambrisentan42%Letairis5%Part D<11 patientsSoluble Guanylate Cyclase Stimulator6.6%Adempas100%Part D<11 patients+ 1 more class in this area
Genitourinary & hormones
38.8%Phosphodiesterase 5 Inhibitor38.8%Tadalafil54%Sildenafil Citrate41%Adcirca6%Part D<11 patientsBlood & clotting
11.5%Prostacycline Vasodilator7.1%Orenitram Er69%Tyvaso Dpi31%Part D<11 patientsProstacyclin Receptor Agonist4.4%Uptravi100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
2 NIH research awards on record, funded 2016–2024 per NIH RePORTER. The latest:
- Diverse effects of hemin on the endothelium contribute to pulmonary complications of sickle cell disease
University of Illinois at Chicago
FY2024$607,535R56HL167875 - The role of NFATc3 in altered hypoxic pulmonary vasoconstriction during acute lung injury
University of Illinois at Chicago
FY2021$76,378K08HL133474 - The role of NFATc3 in altered hypoxic pulmonary vasoconstriction during acute lung injury
University of Illinois at Chicago
FY2020$179,755K08HL133474
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Unveiling the Uncommon: A Case of Spontaneous Fungal Peritonitis in Autoimmune Hepatitis
American Journal of Respiratory and Critical Care Medicine
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Jerry Krishnan, MD
University of Illinois Chicago
Victor Gordeuk, MD
University of Illinois Chicago
Richard Penn, MD
University of Illinois Chicago
William Mieler, MD
University of Illinois Chicago
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”